Clinical trials sponsored by University of Michigan Rogel Cancer Center

Phase breakdown

Conditions studied

Recruiting trials led by University of Michigan Rogel Cancer Center

• A Self-Monitoring Platform for Tracking Medication Safety and Concerns in Cancer Patients
  NCT07291414 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · 2 locations
• Breast Cancer Resiliency Through Exercise Program (B-REP)
  NCT06100263 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: Female · 1 location
• CIPN Decision Aid for the Improvement of Chemotherapy Decision Making in Patients With Breast Cancer
  NCT06915168 · Phase: Not applicable (e.g. observational or device study) · Ages: No age limits stated · Sex: All (male and female) · 1 location
• Evaluation of Stool Based Markers for the Early Detection of Colorectal Cancers and Adenomas
  NCT00843375 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · 13 locations
• Gilteritinib for the Treatment of ALK NSCLC
  NCT06225427 · Phase: Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · 3 locations
• Post-prostatectomy Radiation Therapy--Moderate Versus Ultra-hypofractionated (Also Known as Stereotactic Body Radiation Therapy [SBRT])
  NCT05038332 · Phase: Phase 2 · Ages: 18 Years and older · Sex: Male · 1 location
• Ruxolitinib and Enzalutamide for the Treatment of Metastatic Castration-Resistant Prostate Cancer
  NCT06616155 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: Male · 3 locations
• SPECT/CT Imaging for Dosimetry in 177Lu-PSMA-617 (Pluvicto) Therapy
  NCT07096999 · Phase: Not specified · Ages: 18 Years and older · Sex: Male · 1 location
• Study of Ribociclib Administered Concurrently With Postoperative Radiation Therapy in Patients With High-Risk, HR+/HER2- Breast Cancer
  NCT05996107 · Phase: Phase 1 · Ages: 18 Years and older · Sex: Female · 3 locations
• Targeted Early Detection Program in Men at High Genetic Risk for Prostate Cancer
  NCT07645391 · Phase: Not specified · Ages: 35 Years to 70 Years · Sex: Male · 1 location
• Trial of Exercise Therapy in Familial Adenomatous Polyp (FAP)
  NCT06641310 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · 2 locations

Common questions

How many trials is University of Michigan Rogel Cancer Center recruiting for?

University of Michigan Rogel Cancer Center is the lead sponsor of 11 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.